Interleukin 6 and 12, alanine aminotransferase activity, and HCV viral load in children with chronic hepatitis C treated with interferon and ribavirin

Inflammation

Volumn 28, Issue 6, 2004, Pages 319-325

  Kowala Piaskowska, Arleta ^a   Mozer Lisewska, Iwona ^a   Figlerowicz, Magdalena ^a   Machowska, Ludomiła ^a   Służewski, Wojciech ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

ALT activity; Antiviral treatment; Chronic hepatitis C in children; Interleukin 6 and 12; Viral load of HCV

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2B INTERFERON; INTERLEUKIN 12; INTERLEUKIN 6; RIBAVIRIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CORRELATION ANALYSIS; ENZYME ACTIVITY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; MALE; PROGNOSIS; SCHOOL CHILD; TREATMENT OUTCOME; VIRUS LOAD;

HEPATITIS C VIRUS;

EID: 27144453981     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10753-004-6642-y     Document Type: Article

References (20)

1. Collier, L., and J. Oxford. 1996. Virology. PZWL, Warszawa, pp. 19-78.
2. Nelson, D. R. 2001. The immunopathogenesis of hepatitis C virus infection. Clin. Liver Dis. 5(4):931-953.
3. Mosman, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffmann. 1986. Two types of murine helper T cell clone. 1. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348-2357.
4. Banner, B. F., C. Allan, L. Savas, S. Baker, G. Barnard, and H. L. Bonkovsky. 1997. Inflammatory markers in chronic hepatitis C. Virchows Arch. 431:181-187.
5. Battegay, M. 1996. Immunity to hepatitis C virus: A further piece of the puzzle. Hepatology 10:961-962.
6. Ito, N., S. Kawata, S. Tamura, S. Kiso, H. Tsushima, Y. Maeda, et al. 1996. Induction of interleukin-6 by interferon-α and its abrogation by a serine protease inhibitor in patients with chronic hepatitis C. Hepatology 23:669-675.
7. Malaguarnera, M., I. Di Fazio, A. Laurino, L. Ferlito, M. Romano, and B. A. Trovato. 1997. Serum interleukin 6 concentrations in chronic hepatitis C patients before and after interferon treatment. Int. J. Clin. Pharmacol. Ther. 35(9):385-388.
8. Carreno, V., and J. A. Quiroga. 1997. Biological properties of interleukin-12 and its therapeutic use in persistent hepatitis B virus and hepatitis C virus infection. J. Viral Hepat. 4(Suppl. 2):83-86.
9. Trinchieri, G. 1994. Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84:4008-4027.
10. Jirillo, E., B. Greco, L. Caradonna, R. Satalino, V. Pugliese, and R. Cozzolongo. 1995. Evaluation of cellular immune response and soluble mediators in patients with chronic hepatitis (cHCV) infection. Immunopharmacol. Immunotoxicol. 17:347-364.
11. Martin, J., S. Navas, J. A. Quiroga, G. Colucci, M. Pardo, and V. Carreno. 1998. Quantitation of hepatitis C virus in liver and peripheral blood mononuclear cells from patients with chronic hepatitis C virus infection. J. Med. Virol. 54(4):265-270.
12. Ferrari, C., and F. V. Chisari. 1994. Immune mechanisms of cellular injury in viral hepatitis. In: The Liver Biology and Pathobiology. Raven Press, New York.
13. Tovo, P. A., and M. L. Newell. 1999. Hepatitis C in children. Curr. Opin. Infect. Dis. 12:245-250.
14. Pawłowska, M., W. Halota, E. Topczewska, and A. Kuziemski. 1998. Interferon and ribavirine in the treatment of chronic hepatitis C-preliminary report. Gastroenterologia 5(Suppl. 1):106.
15. Ampurdanes, S., E. Olmedo, M. D. Maluenda, X. Forns, F. X. Lopez-Labrador, J. Costa, et al. 1996. Permanent response to alpha-interferon therapy in chronic hepatitis C is preceded by rapid clearance of HCV-RNA from serum. J. Hepatol. 25:827-832.
16. Gutteman, I. U. 1994. Cytokine therapeutics: Lessons from interferon-α. Proc. Natl. Acad. Sci. USA 91:1198-1205.
17. Wedemeyer, H., W. H. Caselmann, and M. P. Manns. 1998. Combination therapy of chronic hepatitis C: An important step but not the final goal! J. Hepatol. 29:1010-1014.
18. Malaquarnera, M., I. Di Fazio, M. A. Romeo, S. Restuccia, A. Laurino, and B. A. Trovato. 1997. Elevation of interleukin 6 levels in patients with chronic hepatitis due to hepatitis C virus. J. Gastroenterol. 32(2):211-215.
19. Yamashiki, M., A. Nishimura, and H. Suzuki. 1997. Prognosis of chronic hepatitis C patients correlates with circulating monocyte/macrophage function. Clin. Sci. 93:361.
20. Kubin, M., J. M. Chow, and G. Trinchieri. 1994. Differential regulation of interleukin-12 (IL-12), tumor necrosis factor-α and IL-1β production in human myeloid leukemia cell lines and peripheral blood mononuclear cells. Blood 83:1847-1855.